Dank, you are right when you say that the article simply says that Relenza should be used properly.
The problem is that GSK seems to draw the wrong conclusions and want to CANCEL IV RELENZA COMPLETELY:
"Glaxo informed THAT THEY ARE NOT PLANNING TO RECONSTITUTE RELENZA IN ANY LIQUID FORMULATION and is not recommended for use in any nebulizer or mechanical ventilator."
http://topnews.us/content/27645-fda-and-glaxo-issued-warning-proper-use-relenza
I absolutely can NOT understand why GSK acts like this !
They have made many mistakes in the marketing of Relenza before - and it seems that they will never stop...
- Forums
- ASX - By Stock
- fda, glaxo warn of death due to anti-flu medic
Dank, you are right when you say that the article simply says...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online